Literature DB >> 31317585

Quercetin reduces TNF-α-induced mesangial cell proliferation and inhibits PTX3 production: Involvement of NF-κB signaling pathway.

Yue Liu1, Chen Yu2, Kai Ji1, Xuekai Wang1, Xin Li1, Hua Xie1, Yuqing Wang1, Yuting Huang1, Dong Qi3, Huaying Fan1.   

Abstract

Lupus nephritis (LN) is an autoimmune disease caused by systemic lupus erythematosus. Excessive proliferation of mesangial cells is one of the most serious pathological manifestations of LN. In addition, the expression of PTX3 is elevated in the serum of patients with LN. Quercetin has good anti-inflammatory effects and immunomodulatory activities. In this study, the result of MTT indicated that quercetin treatment alleviated the excessive proliferation of mesangial cells. ELISA and immunofluorescence experiments showed that quercetin treatment inhibited the expression of PTX3. Three doses of quercetin (20, 40, and 80 μM) were selected for the experiment. It is noteworthy that the efficacy of quercetin at 80 μM was significantly better than that of other dose groups. And the effect in inhibiting PTX3 expression was comparable with that of the PDTC (80 μM) positive control. Western blot and qRT-PCR analysis revealed that quercetin treatment reduced the expression of nuclear factor-κB p65 and IKKβ, increased the expression of IκBα, and inhibited the expression of PTX3. In conclusion, through inhibiting the activation of nuclear factor-κB signaling pathway, quercetin treatment could reduce the expression of PTX3 and inhibit the excessive proliferation of mesangial cells, suggesting that quercetin is a potential therapeutic drug for LN.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  NF-κB; PTX3; lupus nephritis; quercetin

Year:  2019        PMID: 31317585     DOI: 10.1002/ptr.6430

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

Review 1.  Mesangial Cells in Lupus Nephritis.

Authors:  Tamara K Nowling
Journal:  Curr Rheumatol Rep       Date:  2022-01-05       Impact factor: 4.592

2.  Pentraxin 3 regulated by miR-224-5p modulates macrophage reprogramming and exacerbates osteoarthritis associated synovitis by targeting CD32.

Authors:  Jianbin Yin; Hua Zeng; Kai Fan; Haoyu Xie; Yan Shao; Yuheng Lu; Jinjian Zhu; Zihao Yao; Liangliang Liu; Hongbo Zhang; Bingsheng Luo; Xinjie Wang; Chun Zeng; Xiaochun Bai; Haiyan Zhang; Daozhang Cai
Journal:  Cell Death Dis       Date:  2022-06-24       Impact factor: 9.685

3.  SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis.

Authors:  Mengjun Ma; Wen Yang; Zhaopeng Cai; Peng Wang; Hongyu Li; Rujia Mi; Yuhang Jiang; Zhongyu Xie; Pengfei Sui; Yanfeng Wu; Huiyong Shen
Journal:  Stem Cells       Date:  2021-02-06       Impact factor: 6.277

4.  In Silico Prediction of the Mode of Action of Viola odorata in Diabetes.

Authors:  Manal Ali Buabeid; El-Shaimaa A Arafa; Waseem Hassan; Ghulam Murtaza
Journal:  Biomed Res Int       Date:  2020-10-31       Impact factor: 3.411

5.  Quercetin reverses TNF‑α induced osteogenic damage to human periodontal ligament stem cells by suppressing the NF‑κB/NLRP3 inflammasome pathway.

Authors:  Wenjing Zhang; Linglu Jia; Bin Zhao; Yixuan Xiong; Ya-Nan Wang; Jin Liang; Xin Xu
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

6.  Investigating the Molecular Mechanism of Xijiao Dihuang Decoction for the Treatment of SLE Based on Network Pharmacology and Molecular Docking Analysis.

Authors:  Fangzhi Wei; Yitian Song; Aiming Gong; Chengdan Pan; Yanping Zhuang; Xuan Zhang; Minyu Zeng
Journal:  Biomed Res Int       Date:  2022-01-20       Impact factor: 3.411

Review 7.  Flavonoids in Treatment of Chronic Kidney Disease.

Authors:  Yi-Ling Cao; Ji-Hong Lin; Hans-Peter Hammes; Chun Zhang
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

Review 8.  Lupus nephritis: The regulatory interplay between epigenetic and MicroRNAs.

Authors:  Ning Xu; Jie Liu; Xiangling Li
Journal:  Front Physiol       Date:  2022-09-16       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.